FDA on the Docket at Supreme Court: What to Know Ahead of Abortion-Pill Case, by Judy Roberts

Biden’s Green Policies Will Leave People Freezing This Winter, by John Klar

March 26, 2024

The Women Defying America’s Birth Dearth: An Interview with Catherine Pakaluk

March 26, 2024

Notice: Trying to access array offset on value of type bool in /nas/content/live/brownpelican/wp-content/themes/betheme/functions/theme-functions.php on line 1279

Notice: Trying to access array offset on value of type bool in /nas/content/live/brownpelican/wp-content/themes/betheme/functions/theme-functions.php on line 1284

Notice: Trying to access array offset on value of type bool in /nas/content/live/brownpelican/wp-content/themes/betheme/functions/theme-functions.php on line 1306

Notice: Trying to access array offset on value of type bool in /nas/content/live/brownpelican/wp-content/themes/betheme/functions/theme-functions.php on line 1307

Notice: Trying to access array offset on value of type bool in /nas/content/live/brownpelican/wp-content/themes/betheme/functions/theme-functions.php on line 1308

By Judy Roberts, National Catholic Register - The March 26 hearing before the Supreme Court will mark the first time the high court has considered a major case on abortion since Dobbs in 2022... Abortion advocates like to say their fight for the right to terminate life in the womb is simply about “women’s health,” but that assertion is being challenged by a case going before the U.S. Supreme Court March 26... At stake in Alliance for Hippocratic Medicine v. U.S. FDA is the federal lifting, in 2016 and 2021, of restrictions by the FDA on use of the chemical abortion pill mifepristone, making it easier to obtain. ....

By Judy Roberts, National Catholic Register, March 14, 2024

Judy Roberts Judy Roberts is a journalist who has worked for both the secular and Catholic press. In addition to the Register, she has written for Legatus Magazine, Franciscan Way and Our Sunday Visitor, and is a former religious books reviewer for Publishers Weekly. She also blogs about living more serenely in a busy world at quietkeepers.com.

The March 26 hearing before the Supreme Court will mark the first time the high court has considered a major case on abortion since Dobbs in 2022.

Abortion advocates like to say their fight for the right to terminate life in the womb is simply about “women’s health,” but that assertion is being challenged by a case going before the U.S. Supreme Court March 26.

At stake in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration is the federal lifting, in 2016 and 2021, of restrictions by the Food and Drug Administration (FDA) on use of the chemical abortion pill mifepristone, making it easier to obtain.

In a case originally brought by a group of medical associations and doctors challenging both the drug and the eased restrictions, the U.S. 5th Circuit Court of Appeals ruled in August that the approval of the drug can stand, but the FDA must reinstate the restrictions. ….

FDA on the Docket at Supreme Court: What to Know Ahead of Abortion-Pill Case, by Judy Roberts

Biden’s Green Policies Will Leave People Freezing This Winter, by John Klar

The Women Defying America’s Birth Dearth: An Interview with Catherine Pakaluk

By Judy Roberts, National Catholic Register, March 14, 2024

The March 26 hearing before the Supreme Court will mark the first time the high court has considered a major case on abortion since Dobbs in 2022.

Abortion advocates like to say their fight for the right to terminate life in the womb is simply about “women’s health,” but that assertion is being challenged by a case going before the U.S. Supreme Court March 26.

At stake in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration is the federal lifting, in 2016 and 2021, of restrictions by the Food and Drug Administration (FDA) on use of the chemical abortion pill mifepristone, making it easier to obtain.

In a case originally brought by a group of medical associations and doctors challenging both the drug and the eased restrictions, the U.S. 5th Circuit Court of Appeals ruled in August that the approval of the drug can stand, but the FDA must reinstate the restrictions. ….

Continue reading >>>>>>>>>>>

Related posts

Daily Scripture Readings and Meditations: The Master Will Settle His Account with Them

Another Cakes Case at the Court? by Mary Mobley

Chinese Ambassador Slams President Trump’s Pro-Life Policies at UN, by Steven Ertelt